The Bioabsorbable Stents Market Size was valued at US$ 159.6 million in 2021 and is predicted to reach US$ 165.4 million by the end of 2022. The market is expected to grow at a CAGR of 4.2%, hitting US$ 248.5 Million by 2032. According to a recent study, coronary artery stents will account for around 76.3% of the worldwide Bioabsorbable Stents market in 2021.
Bioabsorbable Stents, as opposed to traditional stents, are made of materials that are easily absorbed by the body and work similarly to traditional medical stents.
Because of their potential to treat coronary artery disease (CAD) without causing long-term problems, bioabsorbable polymeric stents have gained appeal. The study found that biodegradable polymers and copolymers are the preferable materials for Bioabsorbable Stents, and that material processing, mechanical performance, and biodegradability have all improved significantly.
Key Players Included in the Bioabsorbable Stents Market:
- Boston Scientific Corporation
- Meril Life Sciences Pvt. Ltd.
- Medtronic Plc
- Smith Nephew Plc
- Stryker Corporation
- Wright Medical Group
- KLS Martin
- BIOTRONIK Ltd
- Syntellix AG
- Q3 Medical Devices Limited.
- JW Medical Systems LTD
- ORBUSNEICH MEDICAL
- Abbott Vascular
Read More@ https://www.futuremarketinsights.com/reports/bioabsorbable-stents-market
Key Market Segments Covered in Bioabsorbable Stents Industry Research
By Stents:
- Coronary Artery Stents
- Peripheral Artery Stents
- Non-vascular Stents
- Esophageal Stents
- Billary Stents
By Material:
- Metallic
- Ceramic
- Polymers
- PGA
- PLA
- Co-Polymer
By Application:
- Cardiovascular
- Orthopedics
- Cosmetic Surgery
- General Surgery
- Cranial
- Others
By End User:
- Hospitals
- Speciality Clinics
- Ambulatory surgical Centers
